In various models of Parkinson’s disease (PD), the viability of dopaminergic neurons treated with either 6-OH dopamine or MPTP is significantly enhanced after treatment with leptin (Weng et al., 2008; Doherty et al., 2008). Here, LEP is linked to Parkinson disease.